Concepedia

Publication | Closed Access

Efficacy of Rofecoxib, Celecoxib, and Acetaminophen in Osteoarthritis of the Knee

DOI

234

Citations

18

References

2002

Year

Gregory P. Geba, Arthur L. Weaver, Adam B. Polis, Mary Dixon, Thomas J. Schnitzer, for the Mexican Nephrology Collaborative Study Group
JAMA

Abstract

Rofecoxib, 25 mg/d, provided efficacy advantages over acetaminophen, 4000 mg/d, celecoxib, 200 mg/d, and rofecoxib, 12.5 mg, for symptomatic knee OA.

References

YearCitations

Page 1